DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hydroxyurea (Hydroxyurea) - Pneumonia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pneumonia (12)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydroxyurea where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Hydroxyurea side effects in 86 year old male

Reported by a physician from Germany on 2012-07-24

Patient: 86 year old male, weighing 90.0 kg (198.0 pounds)

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Hydroxyurea

Other drugs received by patient: Aspirin; Allopurinol; Torsemide; ACC 200; Cotrim



Possible Hydroxyurea side effects in male

Reported by a physician from Germany on 2012-06-25

Patient: male, weighing 84.8 kg (186.6 pounds)

Reactions: Tumour Lysis Syndrome, Pneumonia, Coronary Artery Disease, Acute Myocardial Infarction, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Inc424
    Dosage: 15 mg, bid
    Administration route: Oral
    Indication: Myelofibrosis
    Start date: 2012-02-28
    End date: 2012-04-22

Hydroxyurea

Other drugs received by patient: Metoprolol Tartrate; Levothyroxine Sodium; Clopidogrel



Possible Hydroxyurea side effects in male

Reported by a physician from Germany on 2012-06-12

Patient: male, weighing 84.8 kg (186.6 pounds)

Reactions: Tumour Lysis Syndrome, Pneumonia, Coronary Artery Disease, Acute Myocardial Infarction, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Inc424
    Dosage: 15 mg, bid
    Administration route: Oral
    Indication: Myelofibrosis
    Start date: 2012-02-28
    End date: 2012-04-22

Hydroxyurea



Possible Hydroxyurea side effects in 82 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04

Patient: 82 year old male, weighing 65.0 kg (143.0 pounds)

Reactions: Pulmonary Sepsis, Pneumonia, Hypotension, Somnolence

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Gemtuzumab Ozogamicin
    Dosage: over 2 hrs on day 8,2nd course on 19jan12 5.6mg,last therapy on 26jan12
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-05

Hydroxyurea
    Dosage: 2nd course on 19jan12
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-05

Azacitidine
    Dosage: route of adm:sc or iv over 10-40min on days 1-7,2nd course on 19jan12 980mg,last therapy on 25jan12
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-05

Other drugs received by patient: Omeprazole; Ciprofloxacin; Biotin; Metoprolol Tartrate; Gabapentin; Fluconazole; Acyclovir



Possible Hydroxyurea side effects in male

Reported by a consumer/non-health professional from Germany on 2012-04-25

Patient: male

Reactions: Pneumonia, Platelet Count Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Hydroxyurea



Possible Hydroxyurea side effects in male

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-04-02

Patient: male

Reactions: Pneumonia, Neoplasm Malignant, Acute Myeloid Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Dasatinib
    Dosage: then 80mg/d for 17 months
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-11-01
    End date: 2010-07-01

Daunorubicin HCL
    Indication: Chronic Myeloid Leukaemia

Azacitidine
    Indication: Chronic Myeloid Leukaemia

Imatinib Mesylate
    Dosage: dose reduced to 300mg/d
    Indication: Chronic Myeloid Leukaemia
    Start date: 2003-01-01
    End date: 2007-12-01

Hydroxyurea
    Indication: Chronic Myeloid Leukaemia

Nilotinib
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-01-01
    End date: 2008-07-01

Cytarabine
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in female

Reported by a physician from Mexico on 2012-03-28

Patient: female

Reactions: Death, Pneumonia, Respiratory Failure, Maternal Exposure During Pregnancy, Venous Insufficiency, Leukocytosis, Splenomegaly, Chronic Myeloid Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydroxyurea
    Dosage: 1500 mg, unk
    Start date: 2011-09-15

Gleevec
    Dosage: 800 mg, unk

Gleevec
    Dosage: 400 mg, day
    Indication: Chronic Myeloid Leukaemia
    Start date: 2011-02-15



Possible Hydroxyurea side effects in 57 year old male

Reported by a physician from Germany on 2012-03-27

Patient: 57 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Disorder, Pneumonia, Cholestasis, Transaminases Increased, Pericardial Effusion, Neoplasm Malignant, Pleural Effusion, Thrombocytopenia, Pneumonitis, Leukopenia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Hydroxyurea
    Dosage: 5 days
    Start date: 2009-09-02

Interferon Alfa
    Dosage: 1df= 1.0 million;08dec2009-dec2010
    Indication: Chronic Myeloid Leukaemia
    Start date: 2009-12-08
    End date: 2010-06-01

Sprycel
    Dosage: paused since 03jan2011 and discontinued on 18jan2011
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia
    End date: 2011-01-18

Imatinib Mesylate
    Dosage: 15sep2009-dec2010
    Indication: Chronic Myeloid Leukaemia
    Start date: 2009-09-15



Possible Hydroxyurea side effects in male

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-03-25

Patient: male

Reactions: Pneumonia, Neoplasm Malignant, Acute Myeloid Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: dose reduced to 300mg/d
    Indication: Chronic Myeloid Leukaemia
    Start date: 2003-01-01
    End date: 2007-12-01

Nilotinib
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-01-01
    End date: 2008-07-01

Daunorubicin HCL
    Indication: Chronic Myeloid Leukaemia

Azacitidine
    Indication: Chronic Myeloid Leukaemia

Dasatinib
    Dosage: then 80mg/d for 17 months
    Indication: Chronic Myeloid Leukaemia
    Start date: 2008-11-01
    End date: 2010-07-01

Hydroxyurea
    Indication: Chronic Myeloid Leukaemia

Cytarabine
    Indication: Chronic Myeloid Leukaemia



Possible Hydroxyurea side effects in female

Reported by a consumer/non-health professional from Mexico on 2012-03-19

Patient: female

Reactions: Pneumonia, Drug Ineffective, Maternal Exposure During Pregnancy, Venous Insufficiency, Death, Respiratory Failure, Splenomegaly, Leukocytosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Gleevec
    Dosage: 400 mg, day
    Indication: Chronic Myeloid Leukaemia
    Start date: 2011-02-15

Gleevec
    Dosage: 800 mg, unk

Hydroxyurea
    Dosage: 1500 mg, unk
    Start date: 2011-09-15



Possible Hydroxyurea side effects in female

Reported by a consumer/non-health professional from Mexico on 2012-03-13

Patient: female

Reactions: Pneumonia, Drug Ineffective, Maternal Exposure During Pregnancy, Venous Insufficiency, Death, Respiratory Failure, Leukocytosis, Splenomegaly

Adverse event resulted in: death

Drug(s) suspected as cause:
Gleevec
    Dosage: 400 mg, day
    Indication: Chronic Myeloid Leukaemia
    Start date: 2011-02-15

Hydroxyurea
    Dosage: 1500 mg, unk
    Start date: 2011-09-15

Gleevec
    Dosage: 800 mg, unk
    Start date: 2011-12-21



Possible Hydroxyurea side effects in male

Reported by a physician from Canada on 2011-11-10

Patient: male, weighing 104.2 kg (229.2 pounds)

Reactions: Renal Failure, Pneumonia, Respiratory Failure, Pain, Haematoma

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Azacitidine
    Dosage: 75 milligram/sq. meter
    Start date: 2011-09-06
    End date: 2011-09-12

Azacitidine
    Dosage: 75 milligram/sq. meter
    Start date: 2011-10-17
    End date: 2011-10-23

Hydroxyurea
    Dosage: 500 milligram
    Administration route: Oral

Septra
    Dosage: 400/80/ 4 tablets
    Administration route: Oral
    End date: 2011-10-01

Allopurinol
    Dosage: 300 milligram
    Administration route: Oral

Other drugs received by patient: Metoprolol; Prednisone TAB; Whole Blood; Digoxin; Levofloxacin; Tinzaparin; Acetaminophen; Flomax; Platelets; Whole Blood; Piperacillin and Tazobactam

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017